# Gingi-Pak A Division of the Belport Co., Inc – FDA Inspection, Jun 9, 2017

Source: https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/c244d7e1-31cf-4070-a34c-b32357131350
Source feed: FDA_Inspections

> FDA inspection 1013526 of Gingi-Pak A Division of the Belport Co., Inc, June 09, 2017. 6 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013526
- Company Name: Gingi-Pak A Division of the Belport Co., Inc
- Inspection Date: 2017-06-09
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1156779 - 2021-11-12](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/17be2adc-9eae-4e94-9044-e54d22235c56)
- FDA Inspection 1082109 - 2019-01-23
- FDA Inspection 896678 - 2014-09-30
- [FDA Inspection 775564 - 2012-03-14](https://www.keypedia.com/records/fda_inspections/gingi-pak-a-division-of-the-belport-co-inc/b0fd05aa-4692-4ed6-b020-1089e61113b2)

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)

Company: https://www.keypedia.com/companies/gingi-pak-a-division-of-the-belport-co-inc/bd9c5700-b0b8-47ae-b992-bef080ddd49e

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b